Qiagen N.V.
QGEN
|
$41.27
-1.48%
320K
|
Health Technology
(0.0% 1d) (-2.2% 1m) (-5.1% 1y) (0.0% 2d) (1.6% 3d) (4.7% 7d) (-22.54% volume)
Earnings Calendar:
Market Cap: $ 9,417,927,699
http://www.qiagen.com
Sec Filling | Patents | 5096 employees
(NL) QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.
genomic molecular diagnostics diagnostics
add to watch list Paper trade email alert is off
Press-releases
QIAGEN N.V. to release results for Q1 2024 and hold webcast
Published: 2024-04-09 (Crawled : 14:00) - globenewswire.com
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -0.41%
H: 1.57%
C: 1.55%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -0.41%
H: 1.57%
C: 1.55%
for results
QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024
Published: 2024-04-03 (Crawled : 20:00) - globenewswire.com
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -1.05%
H: 0.8%
C: -0.87%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -1.05%
H: 0.8%
C: -0.87%
cancer meeting
DNA Methylation Detection Technology Markets, 2033 - Intensified Competition, Increasing Adoption, PCR Dominates
Published: 2024-03-30 (Crawled : 04:20) - prnewswire.com
ABCM | News | $23.99 0.0% 7.4M
|
Health Technology
| Email alert
Add to watchlist
EXAS | $63.595 0.1% 300K
|
Health Technology
| Email alert
Add to watchlist
HOLX | $76.98 -0.27% 210K
|
Health Technology
| Email alert
Add to watchlist
ILMN | $121.3 -2.54% 310K
|
Health Technology
| Email alert
Add to watchlist
PACB | $1.415 -3.74% 3.1M
|
Health Technology
| Email alert
Add to watchlist
QGEN | $41.27 -1.48% 320K
|
Health Technology
| Email alert
Add to watchlist
A | $136.7 -1.8% 470K
|
Health Technology
| Email alert
Add to watchlist
BIO | $278.46 -2.39% 51K
|
Health Technology
| Email alert
Add to watchlist
PKI | $115.24 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
QGEN | $41.27 -1.48% 320K
|
Health Technology
| Email alert
Add to watchlist
ABCZF | News | $22.1 -2.32% 4K
|
Health Technology
| Email alert
Add to watchlist
dna technology
Global Sample Preparation Market Analysis and Outlook 2023-2030 Featuring Profiles of Agilent Technologies, Bio-Rad Labs, Danaher Corp, Illumina, Merck, and Other Key Players
Published: 2024-03-29 (Crawled : 11:00) - prnewswire.com
ILMN | $121.3 -2.54% 310K
|
Health Technology
| Email alert
Add to watchlist
QGEN | $41.27 -1.48% 320K
|
Health Technology
| Email alert
Add to watchlist
A | $136.7 -1.8% 470K
|
Health Technology
| Email alert
Add to watchlist
BIO | $278.46 -2.39% 51K
|
Health Technology
| Email alert
Add to watchlist
DHR | $249.35 -1.49% 1.1M
|
Health Technology
| Email alert
Add to watchlist
PKI | $115.24 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
QGEN | $41.27 -1.48% 320K
|
Health Technology
| Email alert
Add to watchlist
TMO | News | $568.365 -1.08% 680K
|
Health Technology
| Email alert
Add to watchlist
global key market
In Vitro Diagnostics Market Worth $119.4 billion | MarketsandMarkets™
Published: 2024-03-27 (Crawled : 14:30) - prnewswire.com
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.02%
H: 0.28%
C: 0.09%
DHR | $249.35 -1.49% 1.1M
|
Health Technology
|
| O: 0.56%
H: 0.16%
C: -0.43%
BIO | $278.46 -2.39% 51K
|
Health Technology
|
| O: 0.62%
H: 2.18%
C: 2.02%
BDX | $234.225 -0.06% 330K
|
Health Technology
|
| O: 0.57%
H: 1.36%
C: 1.34%
A | $136.7 -1.8% 470K
|
Health Technology
|
| O: 0.86%
H: 1.26%
C: 1.18%
ABT | News | $106.78 -0.75% 2M
|
Health Technology
|
| O: 1.48%
H: 0.0%
C: 0.0%
SRDX | $26.02 -3.34% 7.5K
|
Health Technology
|
| O: 0.99%
H: 2.11%
C: 1.09%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.02%
H: 0.28%
C: 0.09%
ILMN | $121.3 -2.54% 310K
|
Health Technology
|
| O: 1.28%
H: 2.34%
C: 2.34%
HOLX | $76.98 -0.27% 210K
|
Health Technology
|
| O: 0.56%
H: 1.01%
C: 0.98%
AXDX | $0.95 960
|
Health Technology
|
| O: 4.13%
H: 1.0%
C: 1.0%
diagnostics market
QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system
Published: 2024-03-25 (Crawled : 20:00) - globenewswire.com
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -1.59%
H: 1.33%
C: 1.33%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -1.59%
H: 1.33%
C: 1.33%
test system collaboration results
DNA Sequencing Market Projected to Reach $210.34 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-03-22 (Crawled : 01:00) - prnewswire.com
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.34%
H: 0.05%
C: 0.05%
BIO | $278.46 -2.39% 51K
|
Health Technology
|
| O: 0.59%
H: 1.71%
C: -1.02%
A | $136.7 -1.8% 470K
|
Health Technology
|
| O: 0.27%
H: 0.29%
C: -0.94%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.34%
H: 0.05%
C: 0.05%
ILMN | $121.3 -2.54% 310K
|
Health Technology
|
| O: -0.31%
H: 0.34%
C: 0.16%
report reach dna market
QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirements
Published: 2024-03-18 (Crawled : 20:00) - globenewswire.com
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.18%
H: 0.3%
C: -0.47%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.18%
H: 0.3%
C: -0.47%
association international
Europe Biomanufacturing Viral Detection and Quantification Research Report 2023-2032: Research Initiatives to Enhance the Accuracy, Efficiency, and Accessibility of Viral Testing Assays
Published: 2024-03-14 (Crawled : 22:00) - prnewswire.com
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -0.25%
H: 0.57%
C: 0.3%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -0.25%
H: 0.57%
C: 0.3%
europe report research
QIAGEN announces Form 20-F annual report filing for 2023 results
Published: 2024-03-11 (Crawled : 10:00) - globenewswire.com
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.52%
H: 0.83%
C: 0.74%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.52%
H: 0.83%
C: 0.74%
report results
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Qiagen N.V.
QGEN
|
$41.27
-1.48%
320K
|
Health Technology
(0.0% 1d) (-2.2% 1m) (-5.1% 1y) (0.0% 2d) (1.6% 3d) (4.7% 7d) (-22.54% volume)
Earnings Calendar:
Market Cap: $ 9,417,927,699
http://www.qiagen.com
Sec Filling | Patents | 5096 employees
(NL) QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.
genomic molecular diagnostics diagnostics
add to watch list Paper trade email alert is off
Press-releases
QIAGEN N.V. to release results for Q1 2024 and hold webcast
Published: 2024-04-09 (Crawled : 14:00) - globenewswire.com
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -0.41%
H: 1.57%
C: 1.55%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -0.41%
H: 1.57%
C: 1.55%
for results
QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024
Published: 2024-04-03 (Crawled : 20:00) - globenewswire.com
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -1.05%
H: 0.8%
C: -0.87%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -1.05%
H: 0.8%
C: -0.87%
cancer meeting
DNA Methylation Detection Technology Markets, 2033 - Intensified Competition, Increasing Adoption, PCR Dominates
Published: 2024-03-30 (Crawled : 04:20) - prnewswire.com
ABCM | News | $23.99 0.0% 7.4M
|
Health Technology
| Email alert
Add to watchlist
EXAS | $63.595 0.1% 300K
|
Health Technology
| Email alert
Add to watchlist
HOLX | $76.98 -0.27% 210K
|
Health Technology
| Email alert
Add to watchlist
ILMN | $121.3 -2.54% 310K
|
Health Technology
| Email alert
Add to watchlist
PACB | $1.415 -3.74% 3.1M
|
Health Technology
| Email alert
Add to watchlist
QGEN | $41.27 -1.48% 320K
|
Health Technology
| Email alert
Add to watchlist
A | $136.7 -1.8% 470K
|
Health Technology
| Email alert
Add to watchlist
BIO | $278.46 -2.39% 51K
|
Health Technology
| Email alert
Add to watchlist
PKI | $115.24 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
QGEN | $41.27 -1.48% 320K
|
Health Technology
| Email alert
Add to watchlist
ABCZF | News | $22.1 -2.32% 4K
|
Health Technology
| Email alert
Add to watchlist
dna technology
Global Sample Preparation Market Analysis and Outlook 2023-2030 Featuring Profiles of Agilent Technologies, Bio-Rad Labs, Danaher Corp, Illumina, Merck, and Other Key Players
Published: 2024-03-29 (Crawled : 11:00) - prnewswire.com
ILMN | $121.3 -2.54% 310K
|
Health Technology
| Email alert
Add to watchlist
QGEN | $41.27 -1.48% 320K
|
Health Technology
| Email alert
Add to watchlist
A | $136.7 -1.8% 470K
|
Health Technology
| Email alert
Add to watchlist
BIO | $278.46 -2.39% 51K
|
Health Technology
| Email alert
Add to watchlist
DHR | $249.35 -1.49% 1.1M
|
Health Technology
| Email alert
Add to watchlist
PKI | $115.24 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
QGEN | $41.27 -1.48% 320K
|
Health Technology
| Email alert
Add to watchlist
TMO | News | $568.365 -1.08% 680K
|
Health Technology
| Email alert
Add to watchlist
global key market
In Vitro Diagnostics Market Worth $119.4 billion | MarketsandMarkets™
Published: 2024-03-27 (Crawled : 14:30) - prnewswire.com
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.02%
H: 0.28%
C: 0.09%
DHR | $249.35 -1.49% 1.1M
|
Health Technology
|
| O: 0.56%
H: 0.16%
C: -0.43%
BIO | $278.46 -2.39% 51K
|
Health Technology
|
| O: 0.62%
H: 2.18%
C: 2.02%
BDX | $234.225 -0.06% 330K
|
Health Technology
|
| O: 0.57%
H: 1.36%
C: 1.34%
A | $136.7 -1.8% 470K
|
Health Technology
|
| O: 0.86%
H: 1.26%
C: 1.18%
ABT | News | $106.78 -0.75% 2M
|
Health Technology
|
| O: 1.48%
H: 0.0%
C: 0.0%
SRDX | $26.02 -3.34% 7.5K
|
Health Technology
|
| O: 0.99%
H: 2.11%
C: 1.09%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.02%
H: 0.28%
C: 0.09%
ILMN | $121.3 -2.54% 310K
|
Health Technology
|
| O: 1.28%
H: 2.34%
C: 2.34%
HOLX | $76.98 -0.27% 210K
|
Health Technology
|
| O: 0.56%
H: 1.01%
C: 0.98%
AXDX | $0.95 960
|
Health Technology
|
| O: 4.13%
H: 1.0%
C: 1.0%
diagnostics market
QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system
Published: 2024-03-25 (Crawled : 20:00) - globenewswire.com
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -1.59%
H: 1.33%
C: 1.33%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -1.59%
H: 1.33%
C: 1.33%
test system collaboration results
DNA Sequencing Market Projected to Reach $210.34 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-03-22 (Crawled : 01:00) - prnewswire.com
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.34%
H: 0.05%
C: 0.05%
BIO | $278.46 -2.39% 51K
|
Health Technology
|
| O: 0.59%
H: 1.71%
C: -1.02%
A | $136.7 -1.8% 470K
|
Health Technology
|
| O: 0.27%
H: 0.29%
C: -0.94%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.34%
H: 0.05%
C: 0.05%
ILMN | $121.3 -2.54% 310K
|
Health Technology
|
| O: -0.31%
H: 0.34%
C: 0.16%
report reach dna market
QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirements
Published: 2024-03-18 (Crawled : 20:00) - globenewswire.com
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.18%
H: 0.3%
C: -0.47%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.18%
H: 0.3%
C: -0.47%
association international
Europe Biomanufacturing Viral Detection and Quantification Research Report 2023-2032: Research Initiatives to Enhance the Accuracy, Efficiency, and Accessibility of Viral Testing Assays
Published: 2024-03-14 (Crawled : 22:00) - prnewswire.com
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -0.25%
H: 0.57%
C: 0.3%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -0.25%
H: 0.57%
C: 0.3%
europe report research
QIAGEN announces Form 20-F annual report filing for 2023 results
Published: 2024-03-11 (Crawled : 10:00) - globenewswire.com
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.52%
H: 0.83%
C: 0.74%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.52%
H: 0.83%
C: 0.74%
report results
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 55% | 45% |
Top 10 Gainers
CSSE 4 | $0.3499 129.74% 150M
|
Consumer Services
CZOO | $11.04 121.24% 9.6M
|
BOF | $2.05 75.21% 78M
|
AMST | $3.2 60.0% 63M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.05 44.75% 13M
|
Technology Services
TROO | $1.51 38.53% 5.6M
|
Manufacturing
MULN | News | $3.7 35.53% 6.4M
|
Information
RILY | $27.91 28.5% 8.9M
|
Finance
WHLM | $6.43 26.58% 580K
|
Commercial Services
Last 48 Hours Insiders Buying
MNSB P 310 | $15.805 -3.39% 14K
|
Finance
|
15:30
TPL P 3 | $585.24 -0.44% 8K
|
Miscellaneous
|
15:01
ISBA P 966 | $18.0001 3.1K
|
Finance and Insurance
|
15:01
MEGI | $11.97 -0.08% 61K
|
|
00:30
CTRN P 29000 | $22.1 -0.59% 19K
|
Retail Trade
|
22:00
CONN | $3.735 0.95% 21K
|
Retail Trade
|
21:30
TGEN P 6000 | $0.685 6.6K
|
Utilities
|
18:30
CMTV P 700 | $16.59 1K
|
Finance and Insurance
|
18:30
FNB | $13.56 -0.51% 420K
|
Finance
|
17:30
RMCF | $3.54 2.5K
|
Consumer Non-Durables
|
20:10